MicroRNAs, DNA Damage Response, and Cancer Treatment
AbstractAs a result of various stresses, lesions caused by DNA-damaging agents occur constantly in each cell of the human body. Generally, DNA damage is recognized and repaired by the DNA damage response (DDR) machinery, and the cells survive. When repair fails, the genomic integrity of the cell is disrupted—a hallmark of cancer. In addition, the DDR plays a dual role in cancer development and therapy. Cancer radiotherapy and chemotherapy are designed to eliminate cancer cells by inducing DNA damage, which in turn can promote tumorigenesis. Over the past two decades, an increasing number of microRNAs (miRNAs), small noncoding RNAs, have been identified as participating in the processes regulating tumorigenesis and responses to cancer treatment with radiation therapy or genotoxic chemotherapies, by modulating the DDR. The purpose of this review is to summarize the recent findings on how miRNAs regulate the DDR and discuss the therapeutic functions of miRNAs in cancer in the context of DDR regulation. View Full-Text
Share & Cite This Article
He, M.; Zhou, W.; Li, C.; Guo, M. MicroRNAs, DNA Damage Response, and Cancer Treatment. Int. J. Mol. Sci. 2016, 17, 2087.
He M, Zhou W, Li C, Guo M. MicroRNAs, DNA Damage Response, and Cancer Treatment. International Journal of Molecular Sciences. 2016; 17(12):2087.Chicago/Turabian Style
He, Mingyang; Zhou, Weiwei; Li, Chuang; Guo, Mingxiong. 2016. "MicroRNAs, DNA Damage Response, and Cancer Treatment." Int. J. Mol. Sci. 17, no. 12: 2087.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.